OFI Advisors’s United Therapeutics UTHR Stock Holding History

OFI Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$201K	Buy	1,531 +205	+15%	+$32.9K	0.01%	1203
2015 Q2	$231K	Sell	1,326 -254	-16%	-$45.7K	0.01%	1182
2015 Q1	$272K	Buy	1,580 +118	+8%	+$18K	0.02%	1082
2014 Q4	$189K	Sell	1,462 -131	-8%	-$16.9K	0.01%	1235
2014 Q3	$205K	Sell	1,593 -626	-28%	-$64.5K	0.01%	1130
2014 Q2	$196K	Buy	2,219 +517	+30%	+$49.7K	0.01%	1168
2014 Q1	$160K	Buy	1,702 +118	+7%	+$12.1K	0.01%	1219
2013 Q4	$179K	Buy	1,584 +113	+8%	+$10.2K	0.01%	1140
2013 Q3	$116K	Sell	1,471 -123	-8%	-$8.99K	0.01%	1262
2013 Q2	$105K	Buy	+1,594	New	+$103K	0.01%	1239

Other funds holding UTHR

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OFI Advisors's UTHR Position: Q3 2015 in Review

OFI Advisors increased its United Therapeutics (UTHR) stake by 15% in Q3 2015, buying an estimated $32.9K and bringing the position to 1,531 shares worth $201K. The position accounts for 0.01% of the portfolio, ranked #1203.

OFI Advisors first reported a position in UTHR in Q2 2013 and has held it in 10 quarters since. The position peaked at $272K in Q1 2015. 372 funds tracked by Wall St. Rank hold UTHR as of Q3 2015.

OFI Advisors held 1,531 shares of United Therapeutics worth $201K as of Q3 2015.
OFI Advisors bought 205 United Therapeutics shares in Q3 2015, an estimated $32.9K.
United Therapeutics made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1203 holding.
OFI Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's United Therapeutics position peaked at $272K in Q1 2015.
372 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.